熱門資訊> 正文

McKesson将以约22.5亿美元收购精密医疗集团

2026-08-25 20:52

麥克森(MCK) 0

McKesson (MCK) said on Tuesday that it signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialization services, for ~$2.25B.
Following completion of the transaction, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment.
Source: Press Relase

More on McKesson

McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)
McKesson Corporation 2027 Q1 - Results - Earnings Call Presentation
McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript
Cardinal Health a new outperform at RBC on higher margin services
McKesson outlines fiscal 2027 adjusted EPS of $44.20 to $45.00 while planning $5B in share repurchases

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。